288 related articles for article (PubMed ID: 25249621)
1. Nova1 is a master regulator of alternative splicing in pancreatic beta cells.
Villate O; Turatsinze JV; Mascali LG; Grieco FA; Nogueira TC; Cunha DA; Nardelli TR; Sammeth M; Salunkhe VA; Esguerra JL; Eliasson L; Marselli L; Marchetti P; Eizirik DL
Nucleic Acids Res; 2014 Oct; 42(18):11818-30. PubMed ID: 25249621
[TBL] [Abstract][Full Text] [Related]
2. Nova1 or Bim Deficiency in Pancreatic β-Cells Does Not Alter Multiple Low-Dose Streptozotocin-Induced Diabetes and Diet-Induced Obesity in Mice.
Brahma MK; Xiao P; Popa M; Negueruela J; Vandenbempt V; Demine S; Cardozo AK; Gurzov EN
Nutrients; 2022 Sep; 14(18):. PubMed ID: 36145242
[TBL] [Abstract][Full Text] [Related]
3. The human pancreatic islet transcriptome: expression of candidate genes for type 1 diabetes and the impact of pro-inflammatory cytokines.
Eizirik DL; Sammeth M; Bouckenooghe T; Bottu G; Sisino G; Igoillo-Esteve M; Ortis F; Santin I; Colli ML; Barthson J; Bouwens L; Hughes L; Gregory L; Lunter G; Marselli L; Marchetti P; McCarthy MI; Cnop M
PLoS Genet; 2012; 8(3):e1002552. PubMed ID: 22412385
[TBL] [Abstract][Full Text] [Related]
4. Neuron-enriched RNA-binding Proteins Regulate Pancreatic Beta Cell Function and Survival.
Juan-Mateu J; Rech TH; Villate O; Lizarraga-Mollinedo E; Wendt A; Turatsinze JV; Brondani LA; Nardelli TR; Nogueira TC; Esguerra JLS; Alvelos MI; Marchetti P; Eliasson L; Eizirik DL
J Biol Chem; 2017 Feb; 292(8):3466-3480. PubMed ID: 28077579
[TBL] [Abstract][Full Text] [Related]
5. Post-transcriptional regulation of neuro-oncological ventral antigen 1 by the neuronal RNA-binding proteins ELAV.
Ratti A; Fallini C; Colombrita C; Pascale A; Laforenza U; Quattrone A; Silani V
J Biol Chem; 2008 Mar; 283(12):7531-41. PubMed ID: 18218628
[TBL] [Abstract][Full Text] [Related]
6. NOVA1 directs PTBP1 to hTERT pre-mRNA and promotes telomerase activity in cancer cells.
Sayed ME; Yuan L; Robin JD; Tedone E; Batten K; Dahlson N; Wright WE; Shay JW; Ludlow AT
Oncogene; 2019 Apr; 38(16):2937-2952. PubMed ID: 30568224
[TBL] [Abstract][Full Text] [Related]
7. DDX1 regulates alternative splicing and insulin secretion in pancreatic β cells.
Zhong W; Li Z; Zhou M; Xu T; Wang Y
Biochem Biophys Res Commun; 2018 Jun; 500(3):751-757. PubMed ID: 29679569
[TBL] [Abstract][Full Text] [Related]
8. NOVA1 promotes NSCLC proliferation and invasion by activating Wnt/β-catenin signaling.
Qu L; Tian Y; Wang F; Li Z
BMC Cancer; 2022 Oct; 22(1):1091. PubMed ID: 36284263
[TBL] [Abstract][Full Text] [Related]
9. Aberrant NOVA1 function disrupts alternative splicing in early stages of amyotrophic lateral sclerosis.
Krach F; Wheeler EC; Regensburger M; Boerstler T; Wend H; Vu AQ; Wang R; Reischl S; Boldt K; Batra R; Aigner S; Ravits J; Winkler J; Yeo GW; Winner B
Acta Neuropathol; 2022 Sep; 144(3):413-435. PubMed ID: 35778567
[TBL] [Abstract][Full Text] [Related]
10. GLIS3, a susceptibility gene for type 1 and type 2 diabetes, modulates pancreatic beta cell apoptosis via regulation of a splice variant of the BH3-only protein Bim.
Nogueira TC; Paula FM; Villate O; Colli ML; Moura RF; Cunha DA; Marselli L; Marchetti P; Cnop M; Julier C; Eizirik DL
PLoS Genet; 2013 May; 9(5):e1003532. PubMed ID: 23737756
[TBL] [Abstract][Full Text] [Related]
11. NOVA1 acts as an oncogene in melanoma via regulating FOXO3a expression.
Yu X; Zheng H; Chan MTV; Wu WKK
J Cell Mol Med; 2018 May; 22(5):2622-2630. PubMed ID: 29498217
[TBL] [Abstract][Full Text] [Related]
12. Altered splicing machinery in lung carcinoids unveils NOVA1, PRPF8 and SRSF10 as novel candidates to understand tumor biology and expand biomarker discovery.
Blázquez-Encinas R; García-Vioque V; Caro-Cuenca T; Moreno-Montilla MT; Mangili F; Alors-Pérez E; Ventura S; Herrera-Martínez AD; Moreno-Casado P; Calzado MA; Salvatierra Á; Gálvez-Moreno MA; Fernandez-Cuesta L; Foll M; Luque RM; Alcala N; Pedraza-Arevalo S; Ibáñez-Costa A; Castaño JP
J Transl Med; 2023 Dec; 21(1):879. PubMed ID: 38049848
[TBL] [Abstract][Full Text] [Related]
13. Evolutionarily conserved A-to-I editing increases protein stability of the alternative splicing factor Nova1.
Irimia M; Denuc A; Ferran JL; Pernaute B; Puelles L; Roy SW; Garcia-Fernàndez J; Marfany G
RNA Biol; 2012 Jan; 9(1):12-21. PubMed ID: 22258141
[TBL] [Abstract][Full Text] [Related]
14. SRp55 Regulates a Splicing Network That Controls Human Pancreatic β-Cell Function and Survival.
Juan-Mateu J; Alvelos MI; Turatsinze JV; Villate O; Lizarraga-Mollinedo E; Grieco FA; Marroquí L; Bugliani M; Marchetti P; Eizirik DL
Diabetes; 2018 Mar; 67(3):423-436. PubMed ID: 29246973
[TBL] [Abstract][Full Text] [Related]
15. RBM4-Nova1-SRSF6 splicing cascade modulates the development of brown adipocytes.
Lin JC; Chi YL; Peng HY; Lu YH
Biochim Biophys Acta; 2016 Nov; 1859(11):1368-1379. PubMed ID: 27535496
[TBL] [Abstract][Full Text] [Related]
16. NOVA1 prevents overactivation of the unfolded protein response and facilitates chromatin access during human white adipogenesis.
Yang Z; Dong P; Cao J; Lin N; Ma S; Cao R; Cai L; Wang L; Cao C; Xue Y; Pan J; Li X; Wang K; Liu Q; Li C; Gong F; Fu X; Xiao R
Nucleic Acids Res; 2023 Jul; 51(13):6981-6998. PubMed ID: 37246706
[TBL] [Abstract][Full Text] [Related]
17. Reintroduction of the archaic variant of
Trujillo CA; Rice ES; Schaefer NK; Chaim IA; Wheeler EC; Madrigal AA; Buchanan J; Preissl S; Wang A; Negraes PD; Szeto RA; Herai RH; Huseynov A; Ferraz MSA; Borges FS; Kihara AH; Byrne A; Marin M; Vollmers C; Brooks AN; Lautz JD; Semendeferi K; Shapiro B; Yeo GW; Smith SEP; Green RE; Muotri AR
Science; 2021 Feb; 371(6530):. PubMed ID: 33574182
[TBL] [Abstract][Full Text] [Related]
18. Insulin receptor alternative splicing is regulated by insulin signaling and modulates beta cell survival.
Malakar P; Chartarifsky L; Hija A; Leibowitz G; Glaser B; Dor Y; Karni R
Sci Rep; 2016 Aug; 6():31222. PubMed ID: 27526875
[TBL] [Abstract][Full Text] [Related]
19. FoxO feedback control of basal IRS-2 expression in pancreatic β-cells is distinct from that in hepatocytes.
Tsunekawa S; Demozay D; Briaud I; McCuaig J; Accili D; Stein R; Rhodes CJ
Diabetes; 2011 Nov; 60(11):2883-91. PubMed ID: 21933986
[TBL] [Abstract][Full Text] [Related]
20. JNK3 maintains expression of the insulin receptor substrate 2 (IRS2) in insulin-secreting cells: functional consequences for insulin signaling.
Abdelli S; Bonny C
PLoS One; 2012; 7(5):e35997. PubMed ID: 22563476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
